Astria Therapeutics, Inc.: cashflow_financing

Value{"amount": 4433000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2017-01-01 – 2017-09-30
Statuscurrent
EntityAstria Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001104659-17-067354 · Open the official SEC filing →
Retrieved: 2026-08-19T14:22:36.053226+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001454789/cashflow-financing/2017-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/0458636d-649f-4fcd-ade9-fd8f71d818bf

History

From the Record